Tctc Holdings, LLC Gilead Sciences, Inc. Transaction History

Tctc Holdings, LLC

$2.88 Billion
Q3 2024

A detailed history of Tctc Holdings, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tctc Holdings, LLC holds 2,513 shares of GILD stock, worth $229,562. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,513

Previous 3,893 35.45%

Holding current value

$229,562

Previous $267,000 21.35%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$66.59 - $83.99 $91,894 - $115,906	-1,380 Reduced 35.45%	2,513 $210,000
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $1,957 - $2,259	-31 Reduced 0.79%	3,893 $267,000
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $18,610 - $22,695	-260 Reduced 6.21%	3,924 $287,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $2,292 - $2,500	31 Added 0.75%	4,184 $313,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $27,290 - $31,092	353 Added 9.29%	4,153 $344,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $115,292 - $165,519	1,850 Added 94.87%	3,800 $326,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $7,529 - $9,435	-130 Reduced 6.25%	1,950 $116,000
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $8,799 - $9,493	130 Added 6.67%	2,080 $145,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $50,418 - $57,449	-890 Reduced 31.34%	1,950 $114,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $55,269 - $69,491	890 Added 45.64%	2,840 $179,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $159,365 - $185,052	-2,203 Reduced 53.05%	1,950 $150,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $15,627 - $17,250	250 Added 6.41%	4,153 $263,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $23,005 - $30,020	-380 Reduced 8.87%	3,903 $244,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $32,439 - $37,840	-500 Reduced 10.45%	4,283 $303,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $35,575 - $41,760	500 Added 11.67%	4,783 $343,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,283	4,283 $303,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.

Account

Tctc Holdings, LLC Gilead Sciences, Inc. Transaction History